Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

University Hospitals Seidman Cancer Center Provides Personalized Care for Patients with Salivary Gland Cancer

If you or a loved one has been diagnosed with salivary gland cancer, we know the anxiety you must feel. Salivary gland cancer is quite rare, with only 2.5 to 3 cases per 100,000 people in the U.S. annually. However, UH Seidman Cancer Center’s highly skilled physicians and cancer specialists are experts at diagnosing and treating rare cancers, including salivary gland cancer. Using a combination of surgery with chemotherapy and radiation, they can tailor salivary gland cancer treatment to each patient’s individual needs.


Cancer Team Approach Puts Patients First

UH Seidman Cancer Center is a nationally recognized cancer program with expertise in both routine and complex care for every stage of cancer. Our patients benefit from a team approach to their salivary gland cancer care. Our multidisciplinary team performs a disease-specific tumor board review each week. Every single patient has the resources of an entire team of national experts to guide salivary gland cancer care decisions. This review process ensures that all realistic treatment options are considered by a team of specialists. The following team members may be involved in the care and treatment of salivary gland cancer patients:

  • Genetic counselors
  • Medical geneticists
  • Medical oncologists
  • Nurse navigators
  • Nurse practitioners
  • Otolaryngologists
  • Oral surgeons
  • Pathologists
  • Radiation oncologists
  • Radiologists
  • Social workers

Nationally Recognized Cancer Program

At UH Seidman Cancer Center, we deliver a full range of treatment options ranging from conventional methods to leading-edge alternatives. With our high standard of excellence in research and clinical care, UH Seidman Cancer Center is part of the National Cancer Institute-designated Case Comprehensive Cancer Center, one of only 41 comprehensive cancer centers in the country. This means our patients have access to many of the latest drug therapies and advanced treatments not available at other hospitals. Our entire multidisciplinary team evaluates and reviews every single case so diagnosis and treatment decisions are based on the knowledge and proficiency of our team of experts. Together, we work through every step of cancer care.

As innovators and national leaders in head and neck cancer, we offer advanced treatments including:

  • Minimally invasive surgery through endoscopy
  • Reconstructive techniques to preserve quality of life
  • Targeted chemotherapy
  • Precise radiation therapy
  • Access to advanced clinical trials

Salivary Gland Cancer Clinical Trials

UH Seidman Cancer Center has many available clinical trials for patients with salivary gland cancer, including:

  • Studying a cancer drug given with combinations of chemo and antibody for head and neck cancers. Learn more.
  • Studying radiation and chemo with or without a cancer drug. Learn more.